Specify a stock or a cryptocurrency in the search bar to get a summary
BioCorRx Inc
BICXBioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program for substance abuse that includes peer recovery support; and distributes UnCraveRx weight loss management program, a medically assisted weight management program. The company is also developing BICX101, an injectable and implantable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California. Address: 2390 East Orangewood Avenue, Anaheim, CA, United States, 92806
Analytics
WallStreet Target Price
5.1 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BICX
Dividend Analytics BICX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BICX
Stock Valuation BICX
Financials BICX
Results | 2019 | Dynamics |